ABVC Abvc Biopharma Inc
Price (delayed)
$0.6941
Market cap
$8.62M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.66
Enterprise value
$10.29M
Highlights
Abvc Biopharma's EPS has surged by 57% YoY and by 26% QoQ
The debt has plunged by 53% YoY
The gross margin has dropped by 152% year-on-year but it has surged by 97% since the previous quarter
The gross profit has dropped by 109% year-on-year but it has surged by 85% since the previous quarter
The revenue has dropped by 82% year-on-year
Key stats
What are the main financial stats of ABVC
Market
Valuations
Earnings
Shares outstanding
12.42M
Market cap
$8.62M
Enterprise value
$10.29M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.91
Price to sales (P/S)
57.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
75.44
Revenue
$136,396
EBIT
-$8.04M
EBITDA
-$8.01M
Free cash flow
-$3.35M
Per share
Balance sheet
Liquidity
EPS
-$1.66
Free cash flow per share
-$0.3
Book value per share
$0.76
Revenue per share
$0.01
TBVPS
$1.29
Total assets
$14.63M
Total liabilities
$6.81M
Debt
$2.41M
Equity
$8.29M
Working capital
-$4.36M
Debt to equity
0.29
Current ratio
0.33
Quick ratio
0.32
Net debt/EBITDA
-0.21
Margins
Efficiency
Dividend
EBITDA margin
-5,875.8%
Gross margin
-24.1%
Net margin
-8,339%
Operating margin
-6,259.4%
Return on assets
-75.6%
Return on equity
-135.5%
Return on invested capital
-74.9%
Return on capital employed
-99.5%
Return on sales
-5,897.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ABVC stock price
How has the Abvc Biopharma stock price performed over time
Intraday
0.57%
1 week
5.33%
1 month
-1.76%
1 year
-41.67%
YTD
-40.16%
QTD
-10.32%
Financial performance
How have Abvc Biopharma's revenue and profit performed over time
Revenue
$136,396
Gross profit
-$32,891
Operating income
-$8.54M
Net income
-$11.37M
Gross margin
-24.1%
Net margin
-8,339%
The gross margin has dropped by 152% year-on-year but it has surged by 97% since the previous quarter
The gross profit has dropped by 109% year-on-year but it has surged by 85% since the previous quarter
The operating margin has soared by 84% since the previous quarter
The net margin has soared by 83% from the previous quarter
Growth
What is Abvc Biopharma's growth rate over time
Valuation
What is Abvc Biopharma stock price valuation
P/E
N/A
P/B
0.91
P/S
57.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
75.44
Abvc Biopharma's EPS has surged by 57% YoY and by 26% QoQ
The P/B is 17% less than the last 4 quarters average of 1.1
ABVC's equity is up by 6% since the previous quarter
The revenue has dropped by 82% year-on-year
The P/S is 62% lower than the last 4 quarters average of 151.5
Efficiency
How efficient is Abvc Biopharma business performance
Abvc Biopharma's return on sales has surged by 84% QoQ
The company's return on equity has surged by 72% YoY and by 33% QoQ
ABVC's ROIC is up by 49% YoY and by 17% QoQ
The ROA has grown by 40% year-on-year and by 18% since the previous quarter
Dividends
What is ABVC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ABVC.
Financial health
How did Abvc Biopharma financials performed over time
ABVC's total assets is 115% greater than its total liabilities
ABVC's total assets has surged by 57% year-on-year
The total liabilities is down by 30% year-on-year and by 2.4% since the previous quarter
The debt is 71% less than the equity
The debt to equity has surged by 102% year-on-year but it has declined by 6% since the previous quarter
The debt has plunged by 53% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.